C12N 2770/24234
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/24234 (Use of virus or viral component as vaccine) appears on 246 US grants and 391 published applications in this corpus.
Search patents in C12N- Granted patents
- 246
- Published applications
- 391
- Assignees
- 200
- Inventors
- 633
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 0 |
| 2002 | 2 | 13 |
| 2003 | 5 | 12 |
| 2004 | 3 | 12 |
| 2005 | 8 | 18 |
| 2006 | 7 | 18 |
| 2007 | 10 | 16 |
| 2008 | 10 | 14 |
| 2009 | 8 | 25 |
| 2010 | 9 | 28 |
| 2011 | 7 | 29 |
| 2012 | 13 | 21 |
| 2013 | 13 | 14 |
| 2014 | 13 | 26 |
| 2015 | 11 | 17 |
| 2016 | 14 | 18 |
| 2017 | 18 | 16 |
| 2018 | 14 | 11 |
| 2019 | 6 | 4 |
| 2020 | 7 | 12 |
| 2021 | 11 | 13 |
| 2022 | 8 | 10 |
| 2023 | 7 | 12 |
| 2024 | 9 | 17 |
| 2025 | 6 | 10 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for membrane protein structure determination12 May 2026US 12,624,092 B2The Regents of the University of Michigan
- Immunogenic compositions of hepatitis c virus and uses thereof14 Apr 2026US 12,599,661 B2
- Transient expression of biologic materials17 Mar 2026US 12,576,041 B1
- Method of purifying whole virus particles16 Dec 2025US 12,497,598 B2Hvidovre Hospital
- Chimeric antigen receptor polypeptides and methods of using same18 Nov 2025US 12,473,344 B2The Board of Trustees of the Leland Stanford Junior University
- High-yield genotype 1a, 2a and 3a hcv10 Sep 2026US 2026/0263580 A1Hvidovre Hospital
- Zika and hcv attenuated viruses and use thereof2 Jul 2026US 2026/0185060 A1Bar-Ilan University
- Chimeric Antigen Receptor Polypeptides and Methods of Using Same16 Apr 2026US 2026/0103504 A1The Board of Trustees of the Leland Stanford Junior University
- Hcv antigens and antibodies19 Mar 2026US 2026/0078172 A1The Johns Hopkins University
- Vsv vector-encoded hcv envelope proteins e1/e2 as vaccines against hepatitis c virus15 Jan 2026US 2026/0015593 A1Twincore Zentrum FüR Experimentelle Und Klinische Infektionsforschung GmbH
Most cited
By later US patents
- Compositions and methods for delivery of genetic material184US 5,739,118 AApollon Inc. · 1998
- Compositions and methods for delivery of genetic material132US 5,962,428 AApollon Inc. · 1999
- Microparticles with adsorbent surfaces, methods of making same, and uses thereof95US 6,884,435 B1Chiron Corporation · 2005
- Antigen library immunization76US 6,541,011 B2Maxygen, Inc. · 2003
- Yeast-based therapeutic for chronic hepatitis C infection54US 7,439,042 B2GlobeImmune, Inc. · 2008